Darbepoetin alfa
- Generic Name
- Darbepoetin alfa
- Brand Names
- Aranesp
- Drug Type
- Biotech
- CAS Number
- 209810-58-2
- Unique Ingredient Identifier
- 15UQ94PT4P
Overview
Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
Background
Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
Indication
For the treatment of anemia (from renal transplants or certain HIV treatment)
Associated Conditions
- Anemia
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
NESP INJECTION PLASTIC SYRINGE 60 μg/0.5 ml
Manufacturer:Terumo Corporation (Kofu Factory)
Form:INJECTION, SOLUTION, CONCENTRATE
Strength:60 μg
Online:Yes
Approved: 2015/03/02
Approval:SIN14743P
NESP INJECTION PLASTIC SYRINGE 180 μg/0.5 ml
Manufacturer:Terumo Corporation (Kofu Factory)
Form:INJECTION, SOLUTION, CONCENTRATE
Strength:180 μg
Online:Yes
Approved: 2015/03/02
Approval:SIN14745P
NESP INJECTION PLASTIC SYRINGE 120 μg/0.5 ml
Manufacturer:Terumo Corporation (Kofu Factory)
Form:INJECTION, SOLUTION, CONCENTRATE
Strength:120 μg
Online:Yes
Approved: 2015/03/02
Approval:SIN14744P
NESP INJECTION PLASTIC SYRINGE 30 μg/0.5 ml
Manufacturer:Terumo Corporation (Kofu Factory)
Form:INJECTION, SOLUTION, CONCENTRATE
Strength:30 μg
Online:Yes
Approved: 2015/03/02
Approval:SIN14741P
NESP INJECTION PLASTIC SYRINGE 10 μg/0.5 ml
Manufacturer:Terumo Corporation (Kofu Factory)
Form:INJECTION, SOLUTION, CONCENTRATE
Strength:10 μg
Online:Yes
Approved: 2015/03/02
Approval:SIN14739P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath